On August 26, 2019 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported that the Company’s management will present a Company overview and update, as well as host investor meetings, at the following September conferences (Press release, Supernus, AUG 26, 2019, View Source [SID1234538997]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2019 Healthcare Conference
Date: Thursday, September 5, 2019
Time: 1:20 p.m. ET
Place: The Westin Copley Place, Boston, MA

Morgan Stanley 2019 Global Healthcare Conference
Date: Wednesday, September 11, 2019
Time: 11:05 a.m. ET
Place: Grand Hyatt New York in New York City
Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinator.

A live webcast of the presentations can be accessed by visiting ‘Events & Presentations’ in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of these webcasts will be available for 60 days on the Company’s website after the conference.

On August 26, 2019 Gilead Sciences, Inc. (Nasdaq: GILD) reported that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 10 at 10:00 a.m. Eastern Time (Press release, Gilead Sciences, AUG 26, 2019, View Source [SID1234539018]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The audio portion of the fireside chat will be accessible live through the company’s Investors page at View Source Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

On August 26, 2019 Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, reported Marty Duvall, chief executive officer, will present and webcast at the Baird 2019 Global Healthcare Conference in New York on Wednesday, September 4 at 2:30 PM Eastern (Press release, Tocagen, AUG 26, 2019, View Source [SID1234538980]). In addition, Tocagen will participate in Citi’s 14th Annual Biotech Conference in Boston on September 5.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live audio webcast from the Baird Conference and subsequent replay may be accessed by visiting Tocagen’s website. The webcast will be available shortly after conclusion of the presentation and archived on the company’s website for 30 days following the presentation.

On August 26, 2019 Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on developing curative cell therapies for cancer, reported that Charles Wilson, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences in September (Press release, Unum Therapeutics, AUG 26, 2019, View Source [SID1234538998]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 17th Annual Global Healthcare Conference. Fireside chat on Monday, September 9, 2019 at 11:40 a.m. ET in New York City.

H.C. Wainwright 21st Annual Healthcare Conference. Presentation on Tuesday, September 10, 2019 at 10:25 a.m. ET in New York City.

The presentations will be webcast live, available for replay on the "Events" section of Unum’s investor relations webpage (investors.unumrx.com/events), and archived for approximately 90 days.

On August 26, 2019 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system to fight cancer, reported its participation at two upcoming investor conferences in New York City (Press release, Anixa Biosciences, AUG 26, 2019, View Source [SID1234538981]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will provide an overview of the company’s business during live presentations and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences.

Details of Anixa’s presentations are as follows:

Event:

Rodman & Renshaw’s 21st Annual Global Investment Conference

Date:

Monday, September 9, 2019

Time:

2:35 p.m. EDT

Location:

Holmes I (4th Floor)

Lotte New York Palace Hotel, New York, NY

Event:

Janney Healthcare Conference

Date:

Tuesday, September 10, 2019

Time:

11:50 a.m. EDT

Location:

Bates Room

The Union League Club, New York, NY

The Rodman & Renshaw conference presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the investors section of Anixa’s website at View Source